Page last updated: 2024-09-03

bibw 22 and daunorubicin

bibw 22 has been researched along with daunorubicin in 1 studies

Compound Research Comparison

Studies
(bibw 22)
Trials
(bibw 22)
Recent Studies (post-2010)
(bibw 22)
Studies
(daunorubicin)
Trials
(daunorubicin)
Recent Studies (post-2010) (daunorubicin)
6008,2398861,310

Protein Interaction Comparison

ProteinTaxonomybibw 22 (IC50)daunorubicin (IC50)
72 kDa type IV collagenaseHomo sapiens (human)1.9
Multidrug resistance-associated protein 1 Homo sapiens (human)8
Histone deacetylase 1Homo sapiens (human)0.047
Histone deacetylase 8Homo sapiens (human)0.22
Histone deacetylase 6Homo sapiens (human)0.02

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bamberger, U; Esteban, M; Heckel, A; Kasimir-Bauer, S; Müller, MR; Scheulen, ME; Schröder, J; Seeber, S1

Other Studies

1 other study(ies) available for bibw 22 and daunorubicin

ArticleYear
Modulation of multidrug resistance by BIBW22BS in blasts of de novo or relapsed or persistent acute myeloid leukemia ex vivo.
    Journal of cancer research and clinical oncology, 1996, Volume: 122, Issue:5

    Topics: Antigens, CD34; Daunorubicin; Drug Resistance, Multiple; Humans; Idarubicin; Leukemia, Myeloid, Acute; Morpholines; Rhodamine 123; Rhodamines; Triamterene

1996